These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22515422)

  • 1. Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains.
    Chao Y; Makale M; Karmali PP; Sharikov Y; Tsigelny I; Merkulov S; Kesari S; Wrasidlo W; Ruoslahti E; Simberg D
    Bioconjug Chem; 2012 May; 23(5):1003-9. PubMed ID: 22515422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI.
    Chao Y; Karmali PP; Mukthavaram R; Kesari S; Kouznetsova VL; Tsigelny IF; Simberg D
    ACS Nano; 2013 May; 7(5):4289-98. PubMed ID: 23614696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of carbohydrate receptors in the macrophage uptake of dextran-coated iron oxide nanoparticles.
    Chao Y; Karmali PP; Simberg D
    Adv Exp Med Biol; 2012; 733():115-23. PubMed ID: 22101717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.
    Raynal I; Prigent P; Peyramaure S; Najid A; Rebuzzi C; Corot C
    Invest Radiol; 2004 Jan; 39(1):56-63. PubMed ID: 14701989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II.
    Wang G; Serkova NJ; Groman EV; Scheinman RI; Simberg D
    Mol Pharm; 2019 Oct; 16(10):4274-4281. PubMed ID: 31556296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
    Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages.
    Saito S; Tsugeno M; Koto D; Mori Y; Yoshioka Y; Nohara S; Murase K
    Int J Nanomedicine; 2012; 7():5415-21. PubMed ID: 23091384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
    Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
    Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles.
    Islam T; Josephson L
    Cancer Biomark; 2009; 5(2):99-107. PubMed ID: 19414927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negatively charged superparamagnetic iron oxide nanoparticles: a new blood-pooling magnetic resonance contrast agent.
    Nitta N; Tsuchiya K; Sonoda A; Ota S; Ushio N; Takahashi M; Murata K; Nohara S
    Jpn J Radiol; 2012 Dec; 30(10):832-9. PubMed ID: 23001374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging.
    Rogers WJ; Basu P
    Atherosclerosis; 2005 Jan; 178(1):67-73. PubMed ID: 15585202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
    von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
    Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel scavenger receptor-cysteine-rich (SRCR) domain containing scavenger receptor identified from mollusk mediated PAMP recognition and binding.
    Liu L; Yang J; Qiu L; Wang L; Zhang H; Wang M; Vinu SS; Song L
    Dev Comp Immunol; 2011 Feb; 35(2):227-39. PubMed ID: 20888856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs.
    Lee JH; Jung MJ; Hwang YH; Lee YJ; Lee S; Lee DY; Shin H
    Biomaterials; 2012 Jun; 33(19):4861-71. PubMed ID: 22475532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease: MR- and SPECT/CT-based macrophage imaging for monitoring and evaluating disease activity in experimental mouse model--pilot study.
    Wu Y; Briley-Saebo K; Xie J; Zhang R; Wang Z; He C; Tang CY; Tao X
    Radiology; 2014 May; 271(2):400-7. PubMed ID: 24475849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging.
    You DG; Saravanakumar G; Son S; Han HS; Heo R; Kim K; Kwon IC; Lee JY; Park JH
    Carbohydr Polym; 2014 Jan; 101():1225-33. PubMed ID: 24299895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum.
    Banda NK; Mehta G; Chao Y; Wang G; Inturi S; Fossati-Jimack L; Botto M; Wu L; Moghimi SM; Simberg D
    Part Fibre Toxicol; 2014 Nov; 11():64. PubMed ID: 25425420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells.
    Ohtani K; Suzuki Y; Eda S; Kawai T; Kase T; Keshi H; Sakai Y; Fukuoh A; Sakamoto T; Itabe H; Suzutani T; Ogasawara M; Yoshida I; Wakamiya N
    J Biol Chem; 2001 Nov; 276(47):44222-8. PubMed ID: 11564734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines.
    Zhu XM; Wang YX; Leung KC; Lee SF; Zhao F; Wang DW; Lai JM; Wan C; Cheng CH; Ahuja AT
    Int J Nanomedicine; 2012; 7():953-64. PubMed ID: 22393292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid binding of electrostatically stabilized iron oxide nanoparticles to THP-1 monocytic cells via interaction with glycosaminoglycans.
    Ludwig A; Poller WC; Westphal K; Minkwitz S; Lättig-Tünnemann G; Metzkow S; Stangl K; Baumann G; Taupitz M; Wagner S; Schnorr J; Stangl V
    Basic Res Cardiol; 2013 Mar; 108(2):328. PubMed ID: 23314954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.